319 filings
Page 11 of 16
DEF 14C
dzfhuwyd3 moktfzm
2 May 17
Information statement
12:00am
8-K
k6v3g m3kdt
27 Apr 17
Departure of Directors or Certain Officers
12:00am
8-K
k9ypqr1f60j
4 Apr 17
Xenetic Biosciences Expands Executive Management Team with Appointment of
12:00am
PRE 14C
eukc qyqjo
22 Mar 17
Preliminary information
12:00am
8-K
mncza r1znm9yrshfpd
27 Feb 17
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
6fh9yp4
4 Jan 17
Xenetic Biosciences Appoints Curtis A. Lockshin, Ph.D. as Chief Scientific Officer
12:00am
8-K
tjwuwblraqns
6 Dec 16
Xenetic Biosciences Expands Management Team with Key Appointment of Jeffrey F. Eisenberg as Chief Operating Officer
12:00am
8-K
9vjgzk 0t6q6r9pmy
22 Nov 16
Xenetic Biosciences Appoints Edward J. Benz, Jr., M.D., Former Dana-Farber CEO, to its Board of Directors
12:00am
424B4
8srnscry0gy
3 Nov 16
Prospectus supplement with pricing info
12:00am
8-A12B/A
85cahehfxjw7wp 1u
1 Nov 16
Registration of securities on exchange (amended)
12:00am
EFFECT
ucabb33725uik64v1zk
1 Nov 16
Notice of effectiveness
12:00am
8-A12B
f5w2gpz5w xrn
1 Nov 16
Registration of securities on exchange
12:00am
CORRESP
uyc01lhor1g iaa
31 Oct 16
Correspondence with SEC
12:00am
CORRESP
n8z947bzkmpy
31 Oct 16
Correspondence with SEC
12:00am
CORRESP
2golh5lv8 w0
28 Oct 16
Correspondence with SEC
12:00am
CORRESP
eixuc1ii
28 Oct 16
Correspondence with SEC
12:00am